Amylmetacresol
CAS No. 1300-94-3
Amylmetacresol( Amylmetacresol )
Catalog No. M17931 CAS No. 1300-94-3
Amylmetacresol is used in the treatment of sore throat or ‘acute sore throat’, pharyngitis, tonsillitis and laryngitis. As well as in the treatment of influenza A and SARS-CoV.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 26 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAmylmetacresol
-
NoteResearch use only, not for human use.
-
Brief DescriptionAmylmetacresol is used in the treatment of sore throat or ‘acute sore throat’, pharyngitis, tonsillitis and laryngitis. As well as in the treatment of influenza A and SARS-CoV.
-
DescriptionAmylmetacresol is used as a Topical antiseptic for treatment of sore throat.
-
In Vitro——
-
In Vivo——
-
SynonymsAmylmetacresol
-
PathwayAngiogenesis
-
TargetSyk
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1300-94-3
-
Formula Weight178.27
-
Molecular FormulaC12H18O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (560.95 mM)
-
SMILESCCCCCc1ccc(C)cc1O
-
Chemical Name6-Pentyl-m-cresol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mcnally D, et al, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques, 2012, 15(2):281.
molnova catalog
related products
-
Cevidoplenib dimesyl...
Cevidoplenib dimesylate is an inhibitor of spleen tyrosine kinase (Syk), possessing anti-inflammatory and immunomodulating properties.
-
TAK-659 hydrochlorid...
TAK-659 hydrochloride (Mivavotinib, TAK659) is a potent, selective and orally available SYK inhibitor with IC50 of 3.2 nM.
-
Cis-ACBD
2, 4-methanoglutamate is a potent and selective N-methyl-D-aspartate receptor agonist.
Cart
sales@molnova.com